987 results
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Medications for Tobacco ... SR) (tablet) #Pharmacology ... #Smoking #Tobacco
Pharmacotherapy for Smoking Cessation - Table of Short and Long-Acting Agents:

Long Acting: Nicotine Patch, Buproprion, Varenicline
Short
-2/fulltext #Pharmacology ... #Smoking #Tobacco
Smoking Cessation Management
Nicotine Replacement Therapy (NRT):
Long-Acting NRT:
 • Patch: Wear for 24 hours at a time.
Cessation #Management #pharmacology ... #addition #tobacco
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... #Medications #Pharmacology
Pharmacologic Treatment of Hyperthyroidism

#Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Pharmacologic Treatment ... Treatment #Management #Pharmacology
Eosinophilic Pneumonia
When to suspect Eosinophilic Pneumonia? Non-resolving pneumonia + BAL > 25% eosinophils + excluded more
20-40 yo), >40% tobacco ... 30-50 yo, <10% tobacco
Pharmacologic Options for Management of Excited Delirium 
Benzodiazepines
 - Diazepam 
 - Lorazepam 
 - Midazolam
Pharmacologic Options ... Delirium #Management #Pharmacology
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
Pharmacologic prophylaxis ... #indications #pharmacology
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
rehabilitation, tobacco
Risk factors for atherosclerosis

Modifiable risk factors:
 - Dyslipidemia (elevated LDL, decreased HDL)
 - Tobacco smoking
 -
decreased HDL) - Tobacco